🍽🦠 PubMed Studies Citing Bacteria Shifts for Saccharomyces cerevisiae var boulardii {S. boulardii} - Escherichia coli 2-222-05_S1_C3

Citations are updated once a week. Recently added citations may not appear.

5 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
Saccharomyces cerevisiae var boulardii {S. boulardii} - Escherichia coli 2-222-05_S1_C3    👶 Enteral feeding of premature infants with Saccharomyces boulardii.
Early human development (Early Hum Dev ) Vol: 74 Issue 2 Pages: 89-96
Pub: 2003 Nov Epub: Authors Costalos C , Skouteri V , Gounaris A , Sevastiadou S , Triandafilidou A , Ekonomidou C , Kontaxaki F , Petrochilou V ,
Publication
Saccharomyces cerevisiae var boulardii {S. boulardii} - Escherichia coli 2-222-05_S1_C3    👶 Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice.
Journal of applied microbiology (J Appl Microbiol ) Vol: 89 Issue 3 Pages: 404-14
Pub: 2000 Sep Epub: Authors Rodrigues AC , Cara DC , Fretez SH , Cunha FQ , Vieira EC , Nicoli JR , Vieira LQ ,
Publication
Saccharomyces cerevisiae var boulardii {S. boulardii} - Escherichia coli 2-222-05_S1_C3    👶 Heteropolysaccharides from S. cerevisiae show anti-adhesive properties against E. coli associated with Crohn's disease.
Carbohydrate polymers (Carbohydr Polym ) Vol: 271 Issue Pages: 118415
Pub: 2021 Nov 1 Epub: 2021 Jul 8 Authors Sivignon A , Yu SY , Ballet N , Vandekerckove P , Barnich N , Guerardel Y ,
Publication
Saccharomyces cerevisiae var boulardii {S. boulardii} - Escherichia coli 2-222-05_S1_C3    👶 Probiotic yeast Saccharomyces cerevisiae Az-12 isolated from pomegranate juice presented inhibitory effects against pathogenic bacteria.
Brazilian journal of biology = Revista brasleira de biologia (Braz J Biol ) Vol: 83 Issue Pages: e271997
Pub: 2023 Epub: 2023 Aug 11 Authors Latif AS , Saparbekova AA , Akhmedova ZR , Kaldybekova G , Daugaliyeva ST ,
Publication
Saccharomyces cerevisiae var boulardii {S. boulardii} - Escherichia coli 2-222-05_S1_C3    👶 Cytotoxicity assessment and antimicrobial effects of cell-free supernatants from probiotic lactic acid bacteria and yeast against multi-drug resistant Escherichia coli.
Letters in applied microbiology (Lett Appl Microbiol ) Vol: 77 Issue 9 Pages:
Pub: 2024 Sep 2 Epub: Authors Ozma MA , Ghotaslou R , Asgharzadeh M , Abbasi A , Rezaee MA , Kafil HS ,
Publication

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)